PSC Support update
PSC Support Signs Landmark European Declaration to Accelerate Rare Disease Innovation
PSC Support joins European leaders to advocate for a cohesive ecosystem in rare disease care.
Read MoreDriving Global Change Through the Patient Voice
New global survey results reveal the significant impact of itch on life with PSC.
Read MorePrivacy Policy Update 25 February 2026
We’ve updated our Privacy Policy
Read MoreProgress and Plans at the ERN RARE-LIVER Members’ Meeting 2026
Martine Walmsley shares project updates and future goals from the 2026 Prague members’ meeting.
Read MoreLeadership Update
New PSC Support leadership announced
Read MoreMajor Milestone Reached in PSC Cancer Risk Study
100 samples collected: DNA methylation study advances early cancer detection in PSC.
Read MoreJanuary 2026 Research Roundup
PSC Support recently attended the British Association for the Study of the Liver (BASL) Immune Special Interest Group (SIG) meeting. This meeting highlighted important progress in research and care, and on new medications for autoimmune liver diseases.
Read MoreProgress Update: Characterising Genetic Changes in Bile Ducts
PSC research on genetic changes in bile ducts is now in its key analytical phase to unlock understanding.
Read MoreMolecular Signatures Identified to Predict Primary Sclerosing Cholangitis Progression and Cancer Risk
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
Read MorePSC-IBD Bowel Cancer Risk Study Shows Promising Findings
New PSC-IBD research from Dr Chandni Radia suggests bowel cancer risk may be lower than previously thought, helping us build evidence to tailor future colonoscopy guidelines.
Read More